Navicixizumab (DLL4/VEGFA) - Research Grade Biosimilar, Unconjugated, Monoclonal

Artikelnummer: PRS-10-762
Artikelname: Navicixizumab (DLL4/VEGFA) - Research Grade Biosimilar, Unconjugated, Monoclonal
Artikelnummer: PRS-10-762
Hersteller Artikelnummer: 10-762
Alternativnummer: PRS-10-762-0.1
Hersteller: ProSci
Kategorie: Antikörper
Immunogen: Chimeric,Humanized / DLL4/VEGFA [Homo sapiens]
Konjugation: Unconjugated
Alternative Synonym: OMP-305B83
Klonalität: Monoclonal
Konzentration: batch dependent
Puffer: PBS buffer pH7.5
Quelle: CHO cells
Application Verdünnung: Optimal dilutions for each application to be determined by the researcher.